---
title: 'Bleeding events in patients with cancer: incidence, risk factors, and impact
  on prognosis in a prospective cohort study'
date: '2024-08-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39190465/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240828182429&v=2.18.0.post9+e462414
source: Blood
description: Hemostatic imbalances are frequent in patients with cancer. While cancer-associated
  thrombotic complications have been well characterized, data on bleeding events in
  cancer patients are sparse. Therefore, we aimed to investigate the incidence, risk
  factors, and impact on prognosis of bleeding events in cancer patients initiating
  systemic anti-cancer therapies in a prospective cohort study, the Vienna Cancer,
  Thrombosis and Bleeding Study (CAT-BLED). The primary study outcome was defined
  ...
disable_comments: true
---
Hemostatic imbalances are frequent in patients with cancer. While cancer-associated thrombotic complications have been well characterized, data on bleeding events in cancer patients are sparse. Therefore, we aimed to investigate the incidence, risk factors, and impact on prognosis of bleeding events in cancer patients initiating systemic anti-cancer therapies in a prospective cohort study, the Vienna Cancer, Thrombosis and Bleeding Study (CAT-BLED). The primary study outcome was defined ...